|
Mean VAS weights and mean and median TTO weights, per health state |
||||||
| Health state and length of illness |
VAS |
TTO |
||||
|
|
|
|||||
| n |
mean |
median |
mean |
sd |
%0a |
|
|
|
||||||
| Gastroenteritis |
||||||
| Gastroenteritis, mild, 1 day |
51 |
0.036 |
0 |
0.002 |
0.01 |
88 |
| Gastroenteritis, mild, 5 days |
53 |
0.102 |
0 |
0.010 |
0.04 |
60 |
| Gastroenteritis, moderate, 10 days |
107 |
0.130 |
0.005 |
0.015 |
0.04 |
26 |
| Gastroenteritis, severe, 7 days |
53 |
0.231 |
0.008 |
0.025 |
0.05 |
25 |
| Gastroenteritis, severe, 14 days |
51 |
0.295 |
0.011 |
0.041 |
0.07 |
17 |
| Gastroenteritis, chronic, 6 months |
53 |
0.368 |
0.058 |
0.099 |
0.11 |
8 |
| Guillain-Barré syndrome b |
||||||
| Guillain-Barré syndrome, F1, whole year |
51 |
0.185 |
0.008 |
0.044 |
0.09 |
40 |
| Guillain-Barré syndrome, F2, whole year |
107 |
0.420 |
0.077 |
0.137 |
0.18 |
7 |
| Guillain-Barré syndrome, F3, whole year |
53 |
0.545 |
0.153 |
0.215 |
0.23 |
2 |
| Guillain-Barré syndrome, F4, whole year |
51 |
0.700 |
0.252 |
0.367 |
0.32 |
2 |
| Guillain-Barré syndrome, F5, whole year |
53 |
0.722 |
0.403 |
0.460 |
0.31 |
0 |
| Reactive arthritis |
||||||
| Reactive arthritis, mild, 1 week |
51 |
0.107 |
0 |
0.004 |
0.01 |
68 |
| Reactive arthritis, mild, 6 weeks |
53 |
0.197 |
0.011 |
0.023 |
0.03 |
25 |
| Reactive arthritis, moderate, 6 months |
53 |
0.447 |
0.058 |
0.115 |
0.13 |
8 |
| Reactive arthritis, severe, 6 months |
51 |
0.503 |
0.153 |
0.186 |
0.16 |
4 |
| Hemolytic Uremic Syndrome (HUS) |
||||||
| HUS, moderate, 1 month |
53 |
0.279 |
0.022 |
0.056 |
0.08 |
13 |
| HUS, severe, 1 month |
51 |
0.481 |
0.038 |
0.110 |
0.19 |
0 |
| Renal failure, whole year |
51 |
0.628 |
0.252 |
0.328 |
0.25 |
0 |
| Inflammatory bowel disease |
||||||
| Crohn disease, 6 months |
51 |
0.347 |
0.067 |
0.105 |
0.12 |
4 |
| Colitis ulcerosa, 6 months |
53 |
0.492 |
0.115 |
0.154 |
0.15 |
7 |
|
a percentage of participants that were not willing to trade-off any time in order to be restored from the health state. b for a detailed description of the five health states of patients with Guillain-Barré syndrome, see Havelaar et al. [8] | ||||||
Haagsma et al. Population Health Metrics 2008 6:7 doi:10.1186/1478-7954-6-7 |
||||||